An inhibitor was designed to block a biologic function in H. influenzae. If the goal of the experiment were to reduce the virulence of H. influenzae, the most likely target would be
## Core Concept
The question targets the understanding of bacterial virulence factors, specifically those of *Haemophilus influenzae*. *H. influenzae* is a Gram-negative coccobacillus that can cause various infections, ranging from otitis media to life-threatening conditions like meningitis and epiglottitis. The virulence of *H. influenzae* is largely attributed to its polysaccharide capsule, which helps the bacterium evade phagocytosis.
## Why the Correct Answer is Right
The correct answer, **B. polysaccharide capsule synthesis**, is aimed at reducing the virulence of *H. influenzae*. The polysaccharide capsule, primarily composed of polyribosyl ribitol phosphate (PRP), is a critical virulence factor. It protects the bacteria from being phagocytosed by host immune cells. Inhibiting the synthesis of this capsule would render the bacteria more susceptible to phagocytosis and lysis, thereby reducing their virulence.
## Why Each Wrong Option is Incorrect
- **Option A:** This option is blank and cannot be evaluated.
- **Option C:** Without specific details on what "C" represents, it's challenging to directly refute it. However, if it targets other bacterial structures or functions not directly related to evasion of the immune system (like pili, outer membrane proteins, or metabolic pathways), it would be less effective in reducing virulence related to immune evasion.
- **Option D:** Similarly, without specifics, if "D" targets aspects like bacterial adhesion, toxin production, or other virulence factors, it might impact pathogenicity but not necessarily the immune evasion capability as directly as targeting the capsule.
## Clinical Pearl / High-Yield Fact
A critical clinical pearl is that *H. influenzae* type b (Hib) vaccine, which is a polysaccharide-protein conjugate vaccine, has been instrumental in reducing the incidence of invasive Hib disease. The vaccine works by inducing immunity against the PRP capsule, demonstrating the importance of the capsule in virulence and as a target for immune intervention.
## Correct Answer: B. polysaccharide capsule synthesis.